<DOC>
	<DOCNO>NCT00190788</DOCNO>
	<brief_summary>The purpose study determine whether continued administration Drotrecogin Alfa ( Activated ) additional 72 hour - far recommend 96 hour infusion period - result rapid resolution hypotension severe septic patient .</brief_summary>
	<brief_title>Extended Therapy Drotrecogin Alfa ( Activated ) 4 v 7 Days Infusion</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Drotrecogin alfa activate</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<criteria>Severe sepsis patient treat 96 hour infusion commercial Drotrecogin Alfa ( Activated ) Continue requirement Vasopressor support 96 hour commercial infusion Patients require extensive surgical procedure within next 3 day Patients platelet count 30,000/mm3 Patients receive therapeutic heparin 15,000 units/day Patients expect survive 24 day Patients contraindicated country specific registration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>